• 1
    Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991;96:2S4S.
  • 2
    Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnosic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2000;25:603625.
  • 3
    Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade’s clinical experience at the Brigham and Women’s Hospital. J Invest Dermatol 1991;96:5S13S.
  • 4
    Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore) 1988;67:345368.
  • 5
    Brockow K. Urticaria pigmentosa. Immunol Allergy Clin North Am 2004;24:287316.
  • 6
    Roberts LJd. Recurrent syncope due to systemic mastocytosis (clinical conference). Hypertension 1984;6:285294.
  • 7
    Muller UR, Horat W, Wuthrich B, Conroy M, Reisman RE. Anaphylaxis after hymenoptera stings in three patients with urticaria pigmentosa. J Allergy Clin Immunol 1983;72:685689.
  • 8
    Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001;357:361362.
  • 9
    Brockow K, Metcalfe DD. Mastocytosis. Curr Opin Allergy Clin Immunol 2001;1:449454.
  • 10
    Fricker M, Helbling A, Schwartz L, Muller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 1997;100:1115.
  • 11
    Turk J, Oates JA, Roberts LJ 2nd. Intervention with epinephrine in hypotension associated with mastocytosis. J Allergy Clin Immunol 1983;71:189192.
  • 12
    Simpson JK, Brockow K, Turner ML, Akin C, Metcalfe DD. Generalized erythematous macules and plaques associated with flushing, repeated syncope, and refractory anemia. J Am Acad Dermatol 2002;46:588590.
  • 13
    Muller U, Helbling A, Hunziker T, Wuthrich B, Pecoud A, Gilardi S et al. Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa. Allergy 1990;45:597603.
  • 14
    Brockow K, Akin C, Huber M, Metcalfe D. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. J Am Acad Dermatol 2003;48:508516.
  • 15
    Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003;33:12161220.
  • 16
    Oude Elberink JN, De Monchy JG, Kors JW, Van Doormaal JJ, Dubois AE. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol 1997;99(1 part 1):153154.
  • 17
    Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:11441150.
  • 18
    Dodd NJ, Bond MG. Fatal anaphylaxis in systemic mastocytosis. J Clin Pathol 1979;32:3134.
  • 19
    Vaughan ST, Jones GN. Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia 1998;53:804807.
  • 20
    Golitz LE, Weston WL, Lane AT. Bullous mastocytosis: diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme. Pediatr Dermatol 1984;1:288294.
  • 21
    Lucaya J, Perez-Candela V, Aso C, Calvo J. Mastocytosis with skeletal and gastrointestinal involvement in infancy. Two case reports and a review of the literature. Radiology 1979;131:363366.
  • 22
    Murphy M, Walsh D, Drumm B, Watson R. Bullous mastocytosis: a fatal outcome. Pediatr Dermatol 1999;16:452455.
  • 23
    Roberts LJd, Sweetman BJ, Lewis RA, Austen KF, Oates JA. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 1980;303:14001404.
  • 24
    Butterfield JH, Kao PC, Klee GC, Yocum MW. Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization. Mayo Clin Proc 1995;70:481487.
  • 25
    Sutter MC, Beaulieu G, Birt AR. Histamine liberation by codeine and polymyxin B in urticaria pigmentosa. Arch Dermatol 1962;86:217221.
  • 26
    Desborough JP, Taylor I, Hattersley A, Garden A, Wolff A, Bloom SR et al. Massive histamine release in a patient with systemic mastocytosis. Br J Anaesth 1990;65:833836.
  • 27
    Valabhji J, Robinson S, Johnston D, Bellamy M, Davies W, Bain BJ. Unexplained loss of consciousness: systemic mastocytosis. J R Soc Med 2000;93:141142.
  • 28
    Roberts LJd, Fields JP, Oates JA. Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope. Trans Assoc Am Physicians 1982;95:3641.
  • 29
    Valent P, Horny H, Li C, Longley B, Metcalfe D, Parawesch R et al. Mastocytosis. In: JaffeE, HarrisN, SteinH, VardimanJ, editors. World Health Organization classification of tumors pathology and genetics of tumors of hematopoietic and lymphoid tissue. Lyon: IARC Press, 2001:293302.
  • 30
    Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96: 27022710.
  • 31
    Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832836.
  • 32
    Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977;1:466469.
  • 33
    Tufvesson G, Tryding N. Determination of diamine oxidase activity in normal human blood serum. Scand J Clin Lab Invest 1969;24:163168.
  • 34
    Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999;104:452456.
  • 35
    Sorensen HT, Nielsen B, Ostergaard Nielsen J. Anaphylactic shock occurring outside hospitals. Allergy 1989;44:288290.
  • 36
    Orkin M, Good RA, Clawson CC, Fisher I, Windhorst DB. Bullous mastocytosis. Arch Dermatol 1970;101:547564.
  • 37
    Poterack CD, Sheth KJ, Henry DP, Eisenberg C. Shock in an infant with bullous mastocytosis. Pediatr Dermatol 1989;6:122125.
  • 38
    Sicherer SH. Food allergy. Lancet 2002;360:701710.
  • 39
    Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006;97:3943.
  • 40
    Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005;60:443451.
  • 41
    Kemp SF, Lockey RF, Wolf BL, Lieberman P. Anaphylaxis. A review of 266 cases. Arch Intern Med 1995;155:17491754.
  • 42
    Wantke F, Gotz M, Jarisch R. The red wine provocation test: intolerance to histamine as a model for food intolerance. Allergy Proc 1994;15:2732.
  • 43
    Ring J, Darsow U. Idiopathic anaphylaxis. Curr Allergy Asthma Rep 2002;2:4045.
  • 44
    Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 2004;113:347352.
  • 45
    Clark S, Long AA, Gaeta TJ, Camargo CA Jr. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol 2005;116:643649.
  • 46
    Kane KE, Cone DC. Anaphylaxis in the prehospital setting. J Emerg Med 2004;27:371377.
  • 47
    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391397.
  • 48
    Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 2003;33:10331040.
  • 49
    Ring J, Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol 1999;17:387399.